NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Connectomic Guided DBS for Parkinson's Disease

Enrolling By InvitationNA

Sponsor: Duke University

Conditions: Parkinson Disease, Tremor, Dyskinesias

Interventions: Cerebellothalamic optimized deep brain stimulation, Pallidothalamic optimized deep brain stimulation, No deep brain stimulation, Usual care deep brain stimulation

Countries: United States

The objective of this research is to use advanced connectomic imaging models to identify disease-relevant axonal pathway targets for better tremor control in Parkinson's disease patients while avoiding undesirable side effects, with the goal of increasing precision and facilitating the choice of optimal DBS parameters for certain disease phenotypes. The investigators hypothesize that patient centered subthalamic nucleus deep brain stimulation of cerebellothalamic axonal pathways and pallidothalamic tract activation can provide better tremor control while avoiding worsening dyskinesias in patients with Parkinson's disease with significant tremor.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Age 18 or older
* Diagnosed with Parkinson's disease and has previously been implanted with bilateral subthalamic nucleus deep brain stimulation (DBS)
* Received DBS at least three months prior to the time of the study to allow for optimization of usual clinical care
* With at least mild tremor on a pre-operatory MDS-UPDRS clinical scale as defined by at least 2 out of 4 resting tremor grading on MDS-UPDRS on at least one extremity

Exclusion Criteria:

* Not having a post-operative head CT with 1mm or smaller axial slices at least 1 week after initial lead implantation.
* Patients who received DBS less than three months prior to the start of the study

Locations (1)

Durham, North Carolina, United States